Mediators of Atherosclerosis in South Asians Living in America
NCT ID: NCT01207167
Last Updated: 2025-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2314 participants
OBSERVATIONAL
2010-09-30
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study
NCT02268513
Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study
NCT02176174
Atherosclerosis and Omega-3 Fatty Acids in Alaskan Natives
NCT00005236
Coronary Mortality in South Asians: Aetiologic and Prognostic Effects
NCT01163513
Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women
NCT00037258
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 40 and 84 years.
Exclusion Criteria
* Current atrial fibrillation
* Past history of cardiovascular procedures (coronary artery bypass graft (CABG) Surgery, angioplasty, valve replacement, pacemaker or defibrillator implantation, or any surgery on the heart or arteries)
* Active treatment for cancer
* Life expectancy less than 5 years due to serious medical illness
* Impaired cognitive ability as judged by the reviewer
* Plans to move out of the study region in next 5 years
* Weight greater than 300 pounds
* Living in a nursing home or on a waiting list
* Unable to speak/read/write English, Hindi, Urdu, or Bangla
40 Years
84 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
New York University
OTHER
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alka Kanaya, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Namratha Kandula, MD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Nadia Islam, PhD
Role: PRINCIPAL_INVESTIGATOR
New York University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, San Francisco
San Francisco, California, United States
Northwestern University
Chicago, Illinois, United States
New York University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.